Company / Operating Income per Share
Ginkgo Bioworks Holdings, Inc. Operating Income per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$5.80
FY2025
5-year range
-$11.19 / -$0.46
FY2021-FY2025
Trend
+48.2%
vs FY2024
Sector context
#176 of 199
Health Care
What the data says
Ginkgo Bioworks Holdings, Inc.'s operating income per share of $-5.80 is lower than 88% of companies in the Health Care sector (FY2025). Operating Income per Share has fluctuated over the past 7 years, ranging from $-11.19 in FY2024 to $-0.06 in FY2019.
Based on SEC 10-K filings.
-5.80 in FY2025.
Declined from $-0.46 to $-5.80 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 12% in Health CareTop 88% of 199This company -$5.80 Sector average -$3.34
▼
-73.8% below sector average
Key checks
Key Insights
- In FY2025, operating income per share increased 48.2% year-over-year.
- Ranks #176 out of 199 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2019.
- Lowest operating income per share in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$5.80 | +48.2% |
| FY2024 | -$11.19 | -2348.7% |
| FY2023 | -$0.46 | +66.7% |
| FY2022 | -$1.37 | +3.4% |
| FY2021 | -$1.42 | -1220.1% |
| FY2020 | -$0.11 | -72.5% |
| FY2019 | -$0.06 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026